Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 11;2021(2):hoab012.
doi: 10.1093/hropen/hoab012. eCollection 2021.

Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model

Affiliations

Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model

F Zakerkish et al. Hum Reprod Open. .

Abstract

Study question: Do therapeutic levels of cyclosporine-A and tacrolimus affect ovulation in a rat gonadotrophin-induced ovulation model?

Summary answer: Cyclosporine-A, but not tacrolimus, decreases ovulation rate when administered for 5 days before induced ovulation.

What is known already: The mainstays of immunosuppression in solid organ transplantation, to prevent rejection, are the calcineurin inhibitors cyclosporine-A or tacrolimus. These drugs could potentially affect fertility in transplanted patients. Since ovulation is an inflammation-like process with pivotal roles for several immune cells and modulators, it is possible that the calcineurin inhibitors, with broad effects on the immune system, could interfere with this sensitive, biological process.

Study design size duration: Experimental design at university-based animal facilities. A total of 45 immature Sprague-Dawley rats were used. The study was carried out over 3 months.

Participants/materials setting methods: Immature Sprague-Dawley rats (n = 45) were randomly assigned to receive equivalent doses of tacrolimus (0.5 mg/kg/day; TAC), cyclosporine-A (10 mg/kg/day; CyA) or vehicle (Control). Ovarian hyperstimulation was induced with 10 IU of equine chorionic gonadotrophin, and ovulation was triggered with 10 IU of hCG. Oocytes were retrieved from the oviducts and ovulation rates were calculated. Various subpopulations of white blood cells were counted in peripheral blood and ovarian tissue samples.

Main results and the role of chance: Animals in the CyA group showed a lower ovulation rate when compared to the TAC and Control groups (CyA: mean 9 oocytes (range 0-22); TAC: 21 oocytes (8-41); Control: 22 oocytes (6-39); P = 0.03). Regarding counts of the white blood cell subpopulations and resident neutrophils in the ovary, no significant differences were observed between the groups.

Limitations reasons for caution: Although the ovulation process is highly conserved within species, the differences between rodents and humans may limit the external translatability of the study.

Wider implications of the findings: These findings suggest that tacrolimus should be the preferred calcineurin inhibitor of choice in transplanted patients who are aiming for pregnancy.

Study funding/competing interests: Swedish Research Council and ALF of Sahlgrenska Academy, Sweden. Rio Hortega Grant from the Instituto de Salud Carlos III, Spain (CM09/00063). There are no conflicts of interest.

Keywords: calcineurin; cyclosporine-A; immunosuppression; ovary; ovulation; rat; tacrolimus; transplantation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Scheme of the experimental design using a rat gonadotrophin-induced ovulation model. Sprague–Dawley rats were synchronized for ovulation by injecting 10 IU of equine chorionic gonadotrophin (eCG) s.c.; 48 h later, ovulation was induced by injecting 10 IU of hCG i.p. and 20 h after induction, the animals were euthanized by cervical dislocation. During the 7 days prior to euthanasia, the animals received tacrolimus 0.5 mg/kg/day (TAC; n = 15); cyclosporin-A 10 mg/kg/day (CyA; n = 15); or normal saline (Control; n = 15).
Figure 2.
Figure 2.
Ovulation rate outcomes in the rat gonadotrophin-induced ovulation model. Bars represent the median (vertical line) and ranges for the ovulation rate in different groups. Significant differences between Control and CyA group are represented by * (P<0.05). MII: metaphase II.
Figure 3.
Figure 3.
Analysis of ELANE, MPO, RUNX2 and TIMP3 mRNA expression levels in rat ovary. Columns represent fold changes (y-axis) using the control group as reference (1-fold change). Bars represent SDs of delta-Ct measurements. ACTB, actin beta; ELANE, elastase neutrophil expressed; MPO, myeloperoxidase; RUNX2, runt-related transcription factor 2; TIMP3, tissue inhibitor of metalloproteinases.
Figure 4.
Figure 4.
Macrophage distribution within the rat ovaries. Two main patterns of CD163+ cells were identified in rat ovaries. (A) Macrophages around the vascular structures (asterisks). (B) Macrophages within the newly formed corpus luteum. The rectangles delineated by dotted lines are shown at three different magnifications. These images illustrated ovaries from animals in the tacrolimus group.

Similar articles

Cited by

References

    1. Albaghdadi AJH, Feeley CA, Kan FWK.. Low-dose tacrolimus prevents dysregulated peri-conceptional ovarian and systemic immune cellular homeostasis in subjects with PCOS. Sci Rep 2019;9:6528.. - PMC - PubMed
    1. Atilla G, Sorsa T, Ronka H, Emingil G.. Matrix metalloproteinases (MMP-8 and -9) and neutrophil elastase in gingival crevicular fluid of cyclosporin-treated patients. J Periodontol 2001;72:354–360. - PubMed
    1. Barbarino JM, Staatz CE, Venkataramanan R, Klein TE, Altman RB.. PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet Genomics 2013;23:563–585. - PMC - PubMed
    1. Bayer J, Das NA, Baisden CE, Rani M, DeArmond DT, Peters JI, Johnson SB.. Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model. J Thorac Cardiovasc Surg 2013;146:1213–1219; discussion 1219. - PubMed
    1. Brännström M, Johannesson L, Bokström H, Kvarnström N, Mölne J, Dahm-Kähler P, Enskog A, Milenkovic M, Ekberg J, Diaz-Garcia C.. et al. Livebirth after uterus transplantation. The Lancet 2015;385:607–616. - PubMed

LinkOut - more resources